Kathleen Wyne, MD, PhD, FNLA, FACE

Professor-Clinical Medicine
The Ohio State University
Columbus, OH

Dr. Kathleen Wyne is a Professor of Clinical Medicine in the Division of Endocrinology at The Ohio State University in Columbus, Ohio, where she is the Director of the Adult Type 1 Diabetes and the Adult CFRD Program as well as Director of the Diabetes Transition of Care Clinic/Post-Discharge Clinic at OSU East Hospital
She completed an MD and a PhD while working in the Atherosclerosis SCOR at the University of Chicago.
She then completed an Internal Medicine residency at Baylor in Houston Texas followed by a fellowship in Endocrinology, Diabetes & Metabolism at the University of Texas Southwestern in Dallas.
Shei s a Fellow of the American Association of Clinical Endocrinology and a Fellow of the National Lipid Association.
She has served on the National Board of Directors for AACE and the National Lipid Association. She has served on the Clinical Chemistry and Clinical Toxicology Devices Panel for FDA.
She has written guidelines for the Texas Diabetes Council and, most recently, the AACE 2017 Lipid Guideline.
Her current research acitvities are related to cardiovascular risk in T1D and NAFLD/NASH.

Disclosure information not submitted.

Presentation(s):

• Landmark Lipid Trials and Current Lipid Treatment Guidelines

  Saturday, November 19, 2022
  10:40 AM – 11:20 AM EST